Dairy Herd Culling Decisions: Data-Driven Approaches

By Dr. Zubair Khalid, DVM, MS, PhD ·

Dairy Herd Culling Decisions: Data-Driven Approaches

Key Takeaways

  • Data-driven culling decisions integrate production, health, and reproductive data to optimize herd profitability and genetic trajectory, moving beyond reactive removals to a structured replacement benchmark.
  • Bovine Leukemia Virus (BLV) control prioritizes culling of cows with high proviral loads (PVL) and lymphocytosis, identified via quantitative PCR and lymphocyte counts, to mitigate within-herd transmission.
  • Chronic mastitis cases with low bacteriological cure probability, indicated by persistent high somatic cell counts (SCC) and multiple clinical episodes, are strong candidates for culling rather than repeated antimicrobial treatment.
  • Neospora caninum culling decisions are nuanced, requiring consideration of serological status, abortion history, and production attributes, as a single seropositive result without abortion does not automatically warrant removal.
  • Herd turnover rate serves as a diagnostic indicator; a high rate, particularly with a large proportion of involuntary culls, signals underlying management issues in disease control or production efficiency.
  • Economic optimization models for replacement consider heifer cost, milk price, and cow performance, suggesting that retaining cows with single, successfully treated mastitis episodes, especially in early lactation, is often economically sound.

Culling decisions determine the composition, productivity, and genetic trajectory of a dairy herd. This article provides a structured framework for using herd-level data to guide cow removal decisions, with emphasis on economic optimization, disease control, and productive lifespan management. It is written for practicing veterinarians who advise commercial dairy clients and who need defensible, data-based criteria for culling recommendations.

The clinical question addressed here is direct: which cows should leave the herd, when, and on what evidence? The answer requires integrating production records, health events, reproductive status, diagnostic test results, and economic parameters. This first part establishes the conceptual foundation for data-driven culling, including the biology of productive lifespan, the economics of replacement, and the role of herd turnover rate as a management indicator.

At a Glance

ParameterTypical Value or Decision PointData Source
Productive lifespanApproximately 3 years after first calvingHerd records, national databases
Herd turnover rate30% to 40% annually in most confinement herdsDHIA or equivalent milk recording
Culling reason distributionReproduction, mastitis, and lameness account for most removalsHerd health records
Economic optimum for replacementVaries with heifer cost, milk price, and cow performanceDynamic optimization models
BLV control cullingRemove cows with high proviral load and lymphocytosisqPCR and lymphocyte count
Mastitis-related cullingChronic cases with low cure probability are culling candidatesSomatic cell count history, culture results
Neospora abortionSeropositive cows with repeat abortion merit culling considerationELISA serology

Productive Lifespan as a Herd Parameter

Dairy cattle productive lifespan averages approximately 3 years after first calving, a figure that has remained relatively stable despite genetic and management changes. The decision to keep or cull a cow is overwhelmingly economic, and models historically found optimal productive lifespans of 40 months or more for individual cows. Those models, however, were built on performance and price assumptions that may no longer hold. Reproductive efficiency gains and the widespread availability of sexed semen have created an abundance of dairy heifers on many farms, which shortens productive lifespan in herds of fixed size. Genomic testing accelerates genetic gain, and younger herds capitalize on that progress, though they sacrifice the efficiency and lower replacement costs of older cows. De Vries provides a detailed review of these dynamics.

The veterinarian's role is to help the producer distinguish between culling that improves herd profitability and culling that merely reflects heifer availability. A herd with excess heifers may cull marginal cows earlier, but the economic benefit depends on whether the replacement genuinely outperforms the incumbent after accounting for purchase or rearing costs, risk of early lactation disease, and the lag before the heifer reaches peak production.

The Economics of Replacement Decisions

The decision to replace a cow is a capital budgeting problem. The producer compares the expected future income from the current cow against the expected income from a replacement heifer, including the cost of acquiring and raising that heifer. Dynamic optimization models formalize this comparison and have been applied to specific disease conditions. For clinical mastitis, one such model recommended treating affected cows and retaining them in most cases until the fifth lactation, with the optimal culling point shifting earlier when heifer costs were 20% lower and later when heifer costs were 20% higher. The average cost of a clinical mastitis case varied from roughly €112 to €1,006 depending on lactation stage, yield, and culling timing, with costs highest when mastitis occurred at peak yield. Heikkilä and colleagues detail these cost estimates and their sensitivity to replacement assumptions.

These findings carry a practical implication. A cow with a single, successfully treated mastitis episode is often worth retaining, particularly if she is in early lactation and has high yield potential. The culling decision should be driven by expected future performance, not by the occurrence of the disease event itself. Chronic or recurrent cases, by contrast, accumulate costs across multiple episodes and become progressively stronger culling candidates.

Herd Turnover Rate as a Diagnostic Indicator

Herd turnover rate, the percentage of cows leaving the herd annually, is a summary statistic that masks considerable variation in the reasons for and timing of removals. A turnover rate of 30% to 40% is common in confinement systems, but the composition of that turnover matters more than the total. Herds with high involuntary culling for disease or injury have different management problems than herds with high voluntary culling for low production or poor reproduction.

Survey data from Swedish dairy farms found that herd average longevity was associated with only a subset of the farm characteriztics and management routines studied. The use of advisory services and farmer attitudes were among the factors that did correlate with longevity, suggesting that qualitative decision-making influences herd lifespan alongside quantitative measures. Alvåsen and colleagues report these associations in their survey of Swedish dairy farmers. For the veterinarian, this means that improving culling decisions requires attention to the producer's goals and willingness to follow data-based recommendations, also the delivery of better reports.

Disease Control as a Culling Indication

Infectious disease control provides some of the clearest data-driven culling criteria. Bovine leukemia virus (BLV) offers a well-documented example. A minority of BLV-infected cattle have proviral loads in blood and other body fluids exceeding those of other infected cattle by more than 1,000-fold, and when combined with elevated lymphocyte counts, these animals are thought to be responsible for most within-herd transmission. Field trials that identified these high-risk animals and encouraged culling or segregation reduced the incidence of new infections over 2 to 2.5 years. Ruggiero and colleagues describe this intervention and its outcomes in commercial dairy herds. The practical protocol involves semiannual ELISA screening, followed by quantitative PCR and lymphocyte counts on positive animals to identify the most infectious individuals.

Neospora caninum presents a different culling calculus. Infection is a major cause of abortion, and serologic testing identifies infected cows, but the decision to cull depends on the pattern of abortion and the cow's other production attributes. Haddad and colleagues review the Canadian perspective on Neospora diagnosis and control, emphasizing that culling decisions based on test interpretation must account for the limitations of serology and the economic consequences of removing potentially productive animals. A single seropositive cow with no abortion history is not automatically a culling candidate, whereas a seropositive cow with repeat abortions and declining production may be.

Mastitis and the Selective Treatment Framework

Clinical mastitis is responsible for a substantial portion of antimicrobial use on dairy farms, and treatment decisions interact with culling decisions. Recent advances allow exclusion from antimicrobial treatment of nonsevere cases with a high probability of cure without antibiotics, such as those with no bacterial cause or gram-negative infections other than Klebsiella, and cases with a low bacteriological cure rate, such as chronic infections. Rapid diagnostic tests are the most important factor in these selective treatment protocols, and studies have not shown detrimental udder health consequences, including increased culling rates, when such protocols are implemented. de Jong and colleagues provide an evidence-based protocol for selective mastitis treatment.

The connection to culling is twofold. First, cows with chronic mastitis and low cure probability are candidates for culling instead of repeated treatment. Second, the somatic cell count and clinical mastitis history that inform selective treatment decisions are the same data that should inform culling decisions. A cow with persistently elevated somatic cell count, multiple clinical episodes, and a chronic pathogen isolated from culture has a poor prognosis for future productivity and a high probability of infecting herdmates.

The Culling Decision Framework

A defensible culling decision integrates production, reproduction, health, and genetic data into a single expected value calculation. The veterinarian's role is to structure this calculation so that the herd manager applies consistent criteria instead of reacting to individual events. The framework below follows the sequence used in most herd health programs: identify the cow, quantify her current and projected performance, assess her health and disease transmission risk, then compare her expected future value against the replacement heifer available.

Step 1: Define the Replacement Benchmark

Every culling decision is a comparison. The cow's projected future contribution must be weighed against the expected value of the heifer that would replace her. This benchmark changes with heifer supply, genetic merit, and milk price. Farms with abundant heifers, often from improved reproductive efficiency and sexed semen use, tend toward shorter productive lifespans because the opportunity cost of keeping a marginal cow rises when a superior replacement is available. Conversely, herds using beef semen for a portion of the breeding program generate fewer dairy heifers, which raises the value of keeping existing cows longer.

The benchmark should be expressed as a predicted milk yield, a predicted calving interval, and a predicted survival probability for the next lactation. These figures come from the herd's own records, breed association genetic evaluations, and the current heifer inventory. When the herd has no heifers immediately available, the benchmark shifts and some cows that would otherwise be culled are retained.

Step 2: Quantify the Cow's Projected Performance

The cow's own lactation curve, somatic cell count (SCC) history, and reproductive status provide the raw material for projection. A cow in her third or later lactation with declining milk yield relative to herdmates, a rising SCC trajectory, and a prolonged open period has a poor expected future value. The economic models that inform replacement decisions consistently identify these animals as culling candidates, particularly when the mastitis event occurs during the peak yield phase of lactation, where the cost of clinical mastitis is highest.

The projection must account for the probability of recurrence. A cow with one clinical mastitis episode in early lactation has a different risk profile than a cow with three episodes across two lactations. The selective treatment literature emphasizes that chronic cases, identified by repeated episodes and persistently elevated SCC, have low bacteriological cure rates and are poor candidates for continued treatment. These cows should be evaluated for culling instead of treated again.

Step 3: Assess Disease Transmission Risk

Some cows pose a risk to the herd that outweighs their individual production value. The clearest example is bovine leukemia virus (BLV). A minority of BLV-infected cattle carry proviral loads over 1,000 times higher than other infected cattle, and when combined with elevated lymphocyte counts, these animals are responsible for most within-herd transmission. Field trials that identified and removed or segregated these high proviral load cows reduced new infection incidence over two to three years. The testing protocol requires semiannual ELISA screening of adult cows, followed by quantitative PCR and lymphocyte counts on ELISA-positive animals. Herds with a BLV control program should treat high proviral load, high lymphocyte count cows as culling priorities regardless of their milk production.

Neospora caninum presents a different transmission calculus. The infection is a major cause of abortion, and culling decisions based on diagnostic test interpretation are part of the control strategy. However, the economic case for culling a seropositive cow depends on her abortion history, her age, and the herd's prevalence. A young seropositive cow with no abortion history may be worth retaining, while a seropositive cow with recurrent abortions has a poor prognosis for completing a lactation.

Step 4: Apply the Decision Matrix

The table below consolidates the major culling criteria into a prioritization framework. The categories are not mutually exclusive, and a cow may qualify under multiple headings. The veterinarian should assign each candidate cow to the highest applicable priority level.

PriorityCulling CriterionPrimary Data SourceDecision ThresholdNotes
1BLV high proviral load with lymphocytosisqPCR, lymphocyte countPVL > 1,000x median, LC above referenceSegregate if culling not feasible
1Chronic clinical mastitis, low cure probabilityTreatment records, SCC history3+ episodes in current or previous lactationBacteriological cure unlikely
2Neospora abortion repeatAbortion records, serology2+ abortions in consecutive pregnanciesControl program dependent
2Reproductive failureBreeding recordsOpen > 150 days, not pregnant by herd breeding deadlineCompare against heifer availability
3Low milk yield relative to herdmatesDHIA or milk meter recordsBottom 10% of lactation group for 2+ monthsAdjust for stage of lactation
3High SCC with no clinical mastitisSCC recordsSCC > 200,000 cells/mL for 3+ consecutive testsEvaluate for subclinical infection
4Lameness or injury with poor prognosisLocomotion scores, treatment recordsNo improvement after 2 treatment cyclesWelfare consideration overrides economics

Herd-Level Culling Audits

Individual cow decisions accumulate into herd-level outcomes. A quarterly audit of culling reasons, ages at culling, and lactation numbers at culling reveals patterns that individual decisions obscure. The audit should compare the herd's distribution of culling reasons against the expected distribution for the production system. A herd with an unusually high proportion of cows culled for mastitis in early lactation may have a fresh cow management problem instead of an individual cow problem. A herd with rising culling in later lactations may be retaining cows past their economic optimum because heifer supply has tightened.

The audit also tracks the herd turnover rate against the farm's heifer inventory and reproductive performance. Swedish survey data show that herd average longevity is associated with management routines and farmer attitudes, also with the physical facilities. Herds that use advisory services and demonstrate a deliberate approach to culling decisions tend to have longer average productive life. The veterinarian should use the audit to identify whether the herd's culling pattern reflects deliberate policy or reactive decision making.

Documentation and Monitoring Parameters

The culling decision record should capture the reason for culling, the data that supported the decision, and the expected replacement value. This record serves three purposes: it provides a basis for the next audit, it documents disease control decisions for programs such as BLV control, and it creates a feedback loop for the herd's reproductive and health programs. The minimum dataset per culled cow includes identification, lactation number, days in milk, primary culling reason, secondary culling reason, and the date of removal.

Monitoring parameters that detect problems in the culling process include the culling rate by lactation number, the proportion of cows culled in the first 60 days of lactation, the proportion culled for reproductive failure, and the average days open of culled cows. A rising proportion of cows culled in early lactation suggests transition period problems. A rising proportion culled for reproductive failure suggests the breeding program needs review. These parameters should be tracked monthly and reviewed quarterly.

System and Regional Variation

The framework adapts to the production system. Pasture-based herds with seasonal calving have a fixed breeding window, which makes reproductive failure a more absolute culling criterion than in confinement herds with year-round calving. Herds selling milk under a somatic cell count penalty scheme will weight SCC-related culling more heavily than herds without such penalties. The availability of rapid diagnostic tests for mastitis pathogens changes the treatment and culling decision timeline, since on-farm testing allows immediate identification of cases with a high probability of cure without antimicrobials.

Regional disease status also changes the framework. Herds in regions with active BLV control programs will test and cull differently from herds in BLV-free regions. The same principle applies to Neospora control, where the recommended approach depends on local prevalence and the herd's abortion history. The veterinarian should adjust the decision thresholds in the table to reflect the herd's disease status, market conditions, and regulatory environment.

Recognized Complications and Failure Modes

The most common failure of a data-driven culling program is the gradual erosion of decision discipline. When culling criteria are applied inconsistently, the herd turnover rate drifts upward without a corresponding gain in genetic merit or reduction in disease prevalence. This pattern is detectable in the monthly culling audit when the proportion of involuntary culls rises above 40% of total removals for two consecutive months, or when the average days in milk at culling falls below the herd's historical baseline by more than 15 days.

A second failure mode is the substitution of convenience for biology. Cows that are difficult to breed, have chronic lameness, or carry a high somatic cell count are sometimes retained because they are easy to manage or because the milking routine accommodates them. The herd data will show this as a widening gap between the projected and actual performance of retained cows. The discriminating check is a quarterly comparison of actual milk yield, fertility outcomes, and udder health against the projections used in the original culling decision.

A third failure mode involves disease control programs that rely on culling without confirming the diagnostic basis. For bovine leukemia virus control, culling decisions based on proviral load and lymphocyte count require repeat testing to confirm that the identified animals remain the highest-risk transmitters, because PVL can fluctuate with immune status and stage of infection. Similarly, Neospora caninum control programs that cull seropositive cows without accounting for the within-herd transmission dynamics and the risk of reinfection from definitive hosts will not achieve the expected reduction in abortion incidence.

Common Errors and Corrective Actions

Less experienced clinicians often treat culling decisions as a ranking exercise, culling the lowest-producing cows first without considering replacement cost, stage of lactation, or the value of the cow's remaining productive life. The corrective action is to frame every culling decision as a replacement decision: the question is not whether the cow is below average, but whether a replacement heifer would generate more profit over the same period. The economic models that inform this comparison show that the optimal culling point varies with heifer cost, milk price, and the cow's expected future performance.

A second common error is the failure to distinguish between culling for disease control and culling for economic reasons. When a cow is removed because she is infected with a contagious pathogen, the decision should be based on transmission risk, not on her current milk production. The selective mastitis treatment framework demonstrates this distinction: cases with a low probability of bacteriological cure, such as chronic infections, may warrant culling even when the cow is producing well, because the risk of recurrence and transmission outweighs the short-term production value.

A third error is the overinterpretation of single measurements. A single high somatic cell count, a single positive antibody test, or a single low milk yield record does not justify culling. The corrective action is to require a minimum of two confirmatory measurements, spaced appropriately for the condition being evaluated, before a culling decision is finalised.

Limitations of the Evidence and Areas of Expert Disagreement

The economic models that underpin culling recommendations were developed under specific price and production conditions, and their outputs do not transfer directly across regions or production systems. The finding that mastitic cows should generally be retained until the fifth lactation reflects Finnish production conditions, including mandatory veterinary treatment and specific milk prices, and may not apply to herds with different cost structures. Expert opinion differs on the optimal productive lifespan target, with some arguing that accelerated genetic gain from genomic testing justifies shorter lifespans, while others emphasize the environmental and welfare benefits of longer productive lives.

The evidence base for culling as a disease control tool is strongest for mastitis and bovine leukemia virus, and weaker for other conditions. The relationship between herd-level management practices and longevity is only partially explained by the factors studied in survey research, suggesting that qualitative factors, including farmer attitudes and advisory service use, play a substantial role. Practitioners should therefore present culling recommendations as probability-based guidance instead of deterministic rules.

Escalation and Referral Circumstances

Referral or specialist consultation is warranted when the herd-level culling pattern suggests an undiagnosed endemic disease, when the culling rate exceeds 40% annually without a clear economic justification, or when the practitioner lacks the laboratory capacity to confirm a suspected diagnosis. Regulatory reporting obligations apply when culling is considered for diseases subject to official control programs, and the relevant national or international standards should be consulted WOAH terrestrial animal health standards. Laboratory involvement is required for confirmatory testing of bovine leukemia virus proviral load, Neospora serology, and mastitis pathogen identification, and the choice of laboratory test should be guided by the diagnostic question being asked.

Troubleshooting Table

ObservationLikely CauseDiscriminating Check
Culling rate >40% annuallyDecision criteria not applied consistentlyAudit last 20 culling records against the decision matrix
Involuntary culls >50% of removalsDisease control program failingReview disease incidence trends and diagnostic confirmation rates
Average days in milk at culling decliningEconomic criteria overriding disease riskCompare culling reasons against projected performance records
BLV prevalence stable despite cullingCulling not targeting highest PVL animalsVerify PVL and lymphocyte count are current for all culled animals
Mastitis recurrence rate unchangedChronic cases retainedReview bacteriological cure rates for treated and retained cases

Frequently Asked Questions

How Do I Prioritize Culling When Replacement Heifers Are in Short Supply?

When heifer inventory is constrained, the opportunity cost of each replacement rises. The decision matrix shifts toward retaining cows with moderate projected performance, because the alternative is an empty stall or a purchased cow of unknown health status. Prioritize culling for disease transmission risk first, particularly cows with high bovine leukemia virus proviral load or chronic contagious mastitis, since these animals threaten the entire herd. Next, cull cows with terminal conditions or poor prognosis for recovery. Only after these categories should you cull for low production. The economic drivers of productive lifespan remain valid, but the replacement benchmark must be adjusted upward when heifers are scarce, making marginal cows more valuable than the model suggests.

What Minimum Data Set Is Required Before I Can Advise on Culling Decisions?

A functional culling program requires lactation records with monthly test-day milk weights, somatic cell count history, reproductive events with service dates and pregnancy checks, and treatment records with diagnosis codes. Without these, you cannot project future performance or assess transmission risk. At minimum, you need the current lactation number, days in milk, current milk yield relative to herdmates, and somatic cell count linear score. The udder health records used in selective mastitis treatment protocols demonstrate how somatic cell count and clinical mastitis history combine to predict future outcomes. If the herd records only culling dates without reasons, begin by implementing a standardized culling reason classification system before attempting any data-driven recommendations.

How Should I Handle Culling Decisions When Diagnostic Testing Is Not Affordable?

When rapid diagnostic tests or genomic evaluations are unavailable, rely on historical records and physical examination. Chronic mastitis cases can be identified from somatic cell count patterns and repeated clinical episodes without pathogen identification. For Neospora caninum, serological testing of aborting cows remains the standard, but if testing is cost-prohibited, focus on identifying cows with recurrent abortion and culling them based on that history alone. The Canadian perspective on Neospora control emphasizes that interpretation of diagnostic tests improves culling decisions, but where testing is limited, the epidemiological history of the individual cow and her dam becomes the primary evidence. Prioritize testing dollars toward cows that are otherwise borderline culling candidates, not toward cows already scheduled for removal.

What Is the Role of Beef-on-Dairy Semen in Managing Culling Pressure?

Beef semen changes the heifer supply equation. When dairy heifers are abundant, herds often shorten productive lifespan to accelerate genetic gain. Beef semen reduces dairy heifer production, which relieves that pressure and allows longer productive lifespans for high-performing cows. This creates a strategic choice: use beef semen on lower-genetic cows to generate valuable crossbred calves while retaining superior cows longer, or use sexed dairy semen on the best cows to maximize replacement quality. The review of productive lifespan economics notes that sexed semen abundance often shortens lifespans in fixed-size herds, while beef semen does not add to heifer supply. Your culling recommendations should therefore account for the herd's breeding program, since it directly determines the replacement benchmark.

How Do I Present Culling Recommendations to a Herd Owner Who Resists Removing High-Yielding Cows?

Frame the discussion around projected future performance instead of current production. A cow at 12,000 kg in her second lactation may appear valuable, but if she has chronic mastitis with elevated somatic cell count, her projected third lactation will likely be shorter and lower-yielding, and she may infect herdmates. Use the cost estimates for clinical mastitis with premature culling to show that the total cost of keeping a mastitic cow includes her impact on herd infection pressure, also her own milk cheque. Present the decision as a comparison between her projected contribution and the replacement heifer's expected contribution over the next 24 months. Ask the owner to identify their own threshold for acceptable risk of disease transmission, then work backward to the culling criteria.

How Often Should the Herd-Level Culling Policy Be Reviewed?

Review the written culling policy at least twice yearly, aligned with the herd's reproductive calendar. A policy set at dry-off may be obsolete by mid-lactation if milk prices, heifer availability, or disease status has changed. The Swedish survey of farm characteriztics and longevity found that farmer attitudes and advisory service use were associated with longevity outcomes, suggesting that regular external review improves decision consistency. Schedule a formal audit whenever herd turnover rate deviates more than 5 percentage points from the target, or after a disease outbreak that affects culling patterns. Between reviews, monitor monthly culling reports for drift toward convenience culling, which typically appears as an increasing proportion of culls classified as low production without supporting milk yield data.

Related Clinical & Scientific Guides

References and Further Reading

Related Articles

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.